Atlas Brown’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.08M | Sell |
16,181
-34
| -0.2% | -$3.98K | 0.56% | 44 |
|
|
2026
Q1 | $1.95M | Buy |
16,215
+11
| +0.1% | +$1.27K | 0.59% | 44 |
|
|
2025
Q4 | $1.71M | Buy |
16,204
+8
| +0% | +$751 | 0.51% | 52 |
|
|
2025
Q3 | $1.36M | Buy |
16,196
+58
| +0.4% | +$4.78K | 0.4% | 66 |
|
|
2025
Q2 | $1.28M | Buy |
16,138
+143
| +0.9% | +$11.4K | 0.41% | 68 |
|
|
2025
Q1 | $1.44M | Sell |
15,995
-286
| -2% | -$26.7K | 0.5% | 57 |
|
|
2024
Q4 | $1.62M | Buy |
16,281
+613
| +4% | +$63.2K | 0.55% | 48 |
|
|
2024
Q3 | $1.78M | Buy |
15,668
+70
| +0.4% | +$8.32K | 0.62% | 44 |
|
|
2024
Q2 | $1.93M | Sell |
15,598
-841
| -5% | -$108K | 0.69% | 39 |
|
|
2024
Q1 | $2.17M | Buy |
16,439
+939
| +6% | +$116K | 0.79% | 35 |
|
|
2023
Q4 | $1.69M | Sell |
15,500
-62
| -0.4% | -$6.44K | 0.7% | 41 |
|
|
2023
Q3 | $1.6M | Buy |
15,562
+76
| +0.5% | +$8.19K | 0.73% | 38 |
|
|
2023
Q2 | $1.79M | Buy |
15,486
+6
| +0% | +$681 | 0.79% | 36 |
|
|
2023
Q1 | $1.65M | Buy |
15,480
+206
| +1% | +$22.2K | 0.76% | 39 |
|
|
2022
Q4 | $1.69M | Sell |
15,274
-2,789
| -15% | -$285K | 0.83% | 37 |
|
|
2022
Q3 | $1.56M | Buy |
18,063
+90
| +0.5% | +$8.03K | 0.79% | 37 |
|
|
2022
Q2 | $1.64M | Buy |
17,973
+184
| +1% | +$16.3K | 0.77% | 39 |
|
|
2022
Q1 | $1.46M | Buy |
17,789
+13
| +0.1% | +$1.02K | 0.6% | 52 |
|
|
2021
Q4 | $1.36M | Buy |
17,776
+352
| +2% | +$28K | 0.53% | 58 |
|
|
2021
Q3 | $1.31M | Buy |
17,424
+60
| +0.3% | +$4.56K | 0.57% | 55 |
|
|
2021
Q2 | $1.35M | Sell |
17,364
-821
| -5% | -$61.1K | 0.58% | 53 |
|
|
2021
Q1 | $1.34M | Buy |
18,185
+980
| +6% | +$72.3K | 0.63% | 51 |
|
|
2020
Q4 | $1.34M | Buy |
17,205
+322
| +2% | +$24.6K | 0.69% | 45 |
|
|
2020
Q3 | $1.34M | Sell |
16,883
-198
| -1% | -$15.5K | 0.79% | 41 |
|
|
2020
Q2 | $1.26M | Buy |
17,081
+2,252
| +15% | +$170K | 0.8% | 39 |
|
|
2020
Q1 | $1.09M | Buy |
14,829
+293
| +2% | +$23K | 0.85% | 43 |
|
|
2019
Q4 | $1.26M | Buy |
14,536
+1,712
| +13% | +$141K | 0.79% | 43 |
|
|
2019
Q3 | $1.03M | Sell |
12,824
-1,664
| -11% | -$133K | 0.74% | 45 |
|
|
2019
Q2 | $1.16M | Buy |
14,488
+10
| +0.1% | +$766 | 0.8% | 42 |
|
|
2019
Q1 | $1.15M | Sell |
14,478
-1,116
| -7% | -$83.5K | 0.81% | 43 |
|
|
2018
Q4 | $1.14M | Sell |
15,594
-84
| -0.5% | -$5.93K | 0.88% | 43 |
|
|
2018
Q3 | $1.06M | Sell |
15,678
-1,048
| -6% | -$66.8K | 0.65% | 50 |
|
|
2018
Q2 | $994K | Buy |
16,726
+230
| +1% | +$13K | 0.23% | 51 |
|
|
2018
Q1 | $857K | Buy |
16,496
+1,048
| +7% | +$56.6K | 0.16% | 54 |
|
|
2017
Q4 | $902K | Buy |
15,448
+486
| +3% | +$26.9K | 0.16% | 52 |
|
|
2017
Q3 | $914K | Buy |
14,962
+5,239
| +54% | +$318K | 0.19% | 48 |
|
|
2017
Q2 | $595K | Buy |
9,723
+930
| +11% | +$56.6K | 0.52% | 61 |
|
|
2017
Q1 | $533K | Buy |
8,793
+14
| +0.2% | +$849 | 0.42% | 68 |
|
|
2016
Q4 | $523K | Hold |
8,779
| – | – | 0.22% | 63 |
|
|
2016
Q3 | $523K | Buy |
8,779
+390
| +5% | +$22.8K | 0.22% | 63 |
|
|
2016
Q2 | $461K | Sell |
8,389
-1,582
| -16% | -$84.2K | 0.19% | 69 |
|
|
2016
Q1 | $503K | Buy |
9,971
+461
| +5% | +$22.6K | 0.21% | 62 |
|
|
2015
Q4 | $457K | Sell |
9,510
-553
| -5% | -$27.9K | 0.29% | 57 |
|
|
2015
Q3 | $474K | Hold |
10,063
| – | – | 0.2% | 57 |
|
|
2015
Q2 | $561K | Buy |
10,063
+1,470
| +17% | +$82.4K | 0.22% | 55 |
|
|
2015
Q1 | $471K | Buy |
8,593
+1,280
| +18% | +$72.5K | 0.13% | 61 |
|
|
2014
Q4 | $396K | Sell |
7,313
-288
| -4% | -$16K | 0.11% | 74 |
|
|
2014
Q3 | $430K | Sell |
7,601
-234
| -3% | -$13.1K | 0.16% | 65 |
|
|
2014
Q2 | $432K | Buy |
7,835
+1,637
| +26% | +$89.3K | 0.21% | 57 |
|
|
2014
Q1 | $336K | Buy |
6,198
+499
| +9% | +$25.8K | 0.18% | 67 |
|
|
2013
Q4 | $272K | Buy |
5,699
+1,168
| +26% | +$53.4K | 0.19% | 63 |
|
|
2013
Q3 | $206K | Sell |
4,531
-1,879
| -29% | -$85.8K | 0.15% | 71 |
|
|
2013
Q2 | $284K | Buy |
+6,410
| New | +$286K | 0.06% | 110 |
|
Other funds holding MRK
ECSS
Atlas Brown's MRK Position: Q2 2026 in Review
Atlas Brown reduced its Merck (MRK) stake by 0.21% in Q2 2026, selling an estimated $3.98K and leaving 16,181 shares worth $2.08M. The position accounts for 0.56% of the portfolio, ranked #44.
Atlas Brown first reported a position in MRK in Q2 2013 and has held it in 53 quarters since. The position peaked at $2.17M in Q1 2024. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Atlas Brown held 16,181 shares of Merck worth $2.08M as of Q2 2026.
- Atlas Brown sold 34 Merck shares in Q2 2026, an estimated $3.98K.
- Merck made up 0.56% of Atlas Brown's portfolio in Q2 2026, its #44 holding.
- Atlas Brown first reported a position in Merck in Q2 2013 and has held it in 53 quarters since.
- Atlas Brown's Merck position peaked at $2.17M in Q1 2024.
- 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Atlas Brown's 13F filing for Q2 2026, filed 9 Jul 2026.